Apellis Pharmaceuticals, Inc. (APLS)
23.79
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
23.79
0.00 (0.00%)
After-Hours: 17:08
Apellis Pharmaceuticals Profit Margin (Quarterly): 47.04% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 19.00% |
| Amicus Therapeutics, Inc. | 10.24% |
| Fortress Biotech, Inc. | 50.07% |
| Ultragenyx Pharmaceutical, Inc. | -112.8% |
| Fulcrum Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.94% |
| Return on Assets | 5.03% |
| Return on Invested Capital | 6.35% |
| Gross Profit Margin (Quarterly) | 94.58% |
| Operating Margin (Quarterly) | 48.67% |
| Return on Net Operating Assets | 10.69% |